Tolvaptan (OPC-41061), a V2 vasopressin receptor...

Journal of Cardiac Failure 2003 Vol. 9; Iss. 5-supp-S1

Tolvaptan (OPC-41061), a V2 vasopressin receptor antagonist, protects against the decline in renal function observed with loop diuretic therapy

John C. Burnett, William B. Smith, John Ouyang, Christopher A. Zimmer, Cesare Orlandi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Year:
2003
Language:
english
DOI:
10.1016/s1071-9164(03)00234-3
File:
PDF, 55 KB
english, 2003
Conversion to is in progress
Conversion to is failed